VICTORION-2 PREVENT
Objective
The VICTORION-2 PREVENT trial is a randomized double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease.
Research Study Categories
Specialties
- Cardiology
Contact
Cardiology Clinical Trials at 866-839-4128, [email protected]